» Articles » PMID: 33124028

Methods to Investigate MiRNA Function: Focus on Platelet Reactivity

Overview
Journal Thromb Haemost
Publisher Thieme
Date 2020 Oct 30
PMID 33124028
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs (miRNAs) are small noncoding RNAs modulating protein production. They are key players in regulation of cell function and are considered as biomarkers in several diseases. The identification of the proteins they regulate, and their impact on cell physiology, may delineate their role as diagnostic or prognostic markers and identify new therapeutic strategies. During the last 3 decades, development of a large panel of techniques has given rise to multiple models dedicated to the study of miRNAs. Since plasma samples are easily accessible, circulating miRNAs can be studied in clinical trials. To quantify miRNAs in numerous plasma samples, the choice of extraction and purification techniques, as well as normalization procedures, are important for comparisons of miRNA levels in populations and over time. Recent advances in bioinformatics provide tools to identify putative miRNAs targets that can then be validated with dedicated assays. In vitro and in vivo approaches aim to functionally validate candidate miRNAs from correlations and to understand their impact on cellular processes. This review describes the advantages and pitfalls of the available techniques for translational research to study miRNAs with a focus on their role in regulating platelet reactivity.

Citing Articles

MiRNAs and Their Role in Venous Thromboembolic Complications.

Gareev I, Pavlov V, Du W, Yang B Diagnostics (Basel). 2023; 13(21).

PMID: 37958279 PMC: 10650162. DOI: 10.3390/diagnostics13213383.


MicroRNA Expression Profile in Patients Admitted to ICU as Novel and Reliable Approach for Diagnostic and Therapeutic Purposes.

Yan Y, Liao L Mol Biotechnol. 2023; 66(6):1357-1375.

PMID: 37314613 DOI: 10.1007/s12033-023-00767-2.


Establishment of preanalytical conditions for microRNA profile analysis of clinical plasma samples.

Suzuki K, Yamaguchi T, Kohda M, Tanaka M, Takemura H, Wakita M PLoS One. 2022; 17(12):e0278927.

PMID: 36516194 PMC: 9750036. DOI: 10.1371/journal.pone.0278927.


Circulating and Platelet MicroRNAs in Cardiovascular Risk Assessment and Antiplatelet Therapy Monitoring.

Procyk G, Klimczak-Tomaniak D, Sygitowicz G, Tomaniak M J Clin Med. 2022; 11(7).

PMID: 35407371 PMC: 8999342. DOI: 10.3390/jcm11071763.


Circulating MicroRNAs for Diagnosis of Acute Pulmonary Embolism: Still a Long Way to Go.

Sobrero M, Montecucco F, Carbone F Biomed Res Int. 2022; 2022:4180215.

PMID: 35047634 PMC: 8763471. DOI: 10.1155/2022/4180215.


References
1.
Lataniotis L, Albrecht A, Kok F, Monfries C, Benedetti L, Lawson N . CRISPR/Cas9 editing reveals novel mechanisms of clustered microRNA regulation and function. Sci Rep. 2017; 7(1):8585. PMC: 5561095. DOI: 10.1038/s41598-017-09268-0. View

2.
Leblanc R, Peyruchaud O . Metastasis: new functional implications of platelets and megakaryocytes. Blood. 2016; 128(1):24-31. DOI: 10.1182/blood-2016-01-636399. View

3.
Yang J, Lai E . Alternative miRNA biogenesis pathways and the interpretation of core miRNA pathway mutants. Mol Cell. 2011; 43(6):892-903. PMC: 3176435. DOI: 10.1016/j.molcel.2011.07.024. View

4.
Jin Y, Chen Z, Liu X, Zhou X . Evaluating the microRNA targeting sites by luciferase reporter gene assay. Methods Mol Biol. 2012; 936:117-27. PMC: 3646406. DOI: 10.1007/978-1-62703-083-0_10. View

5.
Cao F, Xie X, Gollan T, Zhao L, Narsinh K, Lee R . Comparison of gene-transfer efficiency in human embryonic stem cells. Mol Imaging Biol. 2009; 12(1):15-24. PMC: 2803751. DOI: 10.1007/s11307-009-0236-x. View